The Prevalence and Risk Factors for Hepatitis B Surface Ag Positivity in Pregnant Women in Eastern Region of Ghana by Cho, Younmo et al.
ORiginal Article
Gut and Liver, Vol. 6, No. 2, April 2012, pp. 235-240
The Prevalence and Risk Factors for Hepatitis B Surface Ag Positivity in 
Pregnant Women in Eastern Region of Ghana
Younmo Cho*, George Bonsu
†, Arko Akoto-Ampaw
‡, Grace Nkrumah-Mills
§, Julia J.A. Nimo
∥, Jin Kyung Park
¶, and Moran 
Ki*
*Department of Preventive Medicine, Eulji University School of Medicine, Daejeon, Korea, 
†Eastern Region Public Health Division, Koforidua, 
Ghana, 
‡Asesewa Government Hospital and Upper Manya Krobo District Health Administration, Asesewa, Ghana, 
§Yilo Krobo District Health 
Administration, Somanya, Ghana, 
∥ Holy Family Hospital and Kwahu West District Health Administration, Nkawkaw, Ghana, and 
¶Translational 
Research Division, International Vaccine Institute, Seoul, Korea
Background/Aims: The aim of this study was to evaluate the 
prevalence and risk factors for hepatitis B surface antigen 
(HBsAg) positivity in pregnant Ghanaian women. Methods: 
We surveyed 1,500 pregnant women in Eastern region of 
Ghana. Direct interviews were performed by trained nurses 
using standardized questionnaires. Pregnant women were 
screened for human immunodeﬁ  ciency virus (HIV) and hepa-
titis B infections, hemoglobin levels and sickle cell anemia as 
part of the antenatal check-up. Results: The overall HBsAg 
positive rate was 10.6%, which varied among districts (13.8% 
for Kwahu West, 12.4% for Upper Manya, and 2.2% for Yilo 
Krobo). HBsAg positivity was significantly higher in women 
with depression (odds ratio [OR], 3.74; 95% confidence in-
terval [CI], 2.13 to 6.57) and HIV (OR, 2.03; 95% CI, 1.06 to 
3.89). Age, education, and gravidity were not related to HB-
sAg positivity. Anti-hepatitis B immunoglobulin for newborns 
of HBsAg-positive mothers is not provided at birth in public 
health facilities in Ghana. However, hepatitis B vaccination 
is provided as part of a routine vaccination schedule start-
ing at 6 weeks of age. Conclusions: To prevent mother-to-
child transmission of hepatitis B, screening tests for HBsAg 
in pregnant women and hepatitis B vaccination of newborns 
immediately after birth need to be performed in this region.   
(Gut Liver 2012;6:235-240)
Key Words: Hepatitis B; Ghana; Pregnant women; Risk fac-
tors; Prevalence
INTRODUCTION
It has been reported that general health state in Eastern 
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Ghana is lower than that of other areas in the same country. In 
2009, the life expectancy at birth of Ghanaian men and women 
are 57 and 64 years respectively, with under-five mortality rate 
(probability of dying by age 5 per 1,000 live births) reaching 
69,
1 a per capita total expenditure on health (PPP int. $) was 
$122 and total expenditure on health as a percentage of gross 
domestic product was 8.1% in 2009 according to World Health 
Organization (WHO) statistics.
2 However, it was $100 in Eastern 
Ghana. The number of physicians per 10,000 is 0.85 in Ghana,
2 
and Eastern region is lower than this in 2009.
3 Sub-Saharan 
Africa including Ghana is a highly endemic area of hepatitis B, 
reaching up to approximately 90% carrier rate in some rural ar-
eas.
4 The hepatitis B prevention strategy of WHO states that rou-
tine infant immunization is required for all countries and addi-
tional vaccination is needed in accordance with every country’s 
epidemiological characteristic. Hepatitis B virus (HBV) birth dose 
(vaccination in 24 hours) is recommended for countries with 
hepatitis B surface antigen (HBsAg) prevalence higher than 8%.
5 
Currently, an average Ghanaian receives vaccination routinely 
as part of the pentavalent vaccine including diphtheria, pertus-
sis, tetanus, and haemophilus influenza type b at 6, 10, and 14 
weeks after birth, respectively, but not immediately after birth. 
It is established that the main HBV transmission path of Sub-
Saharan Africa is horizontal,
6,7 but attention also needs to be 
given to the vertical transmission considering previous reports 
that most of the HBV infected children of this area was infected 
before the age of five.
6,7 Under these circumstances, maternal 
and child health services is vital, yet little information is avail-
able on HBsAg prevalence of pregnant Ghanaian women. The 
more pregnant women are exposed to HBV, the higher the risk 
of vertical transmission which in turn keeps hepatitis B endemic. 236  Gut and Liver, Vol. 6, No. 2, April 2012
This study sought to investigate the HBsAg prevalence, as well 
as risk factors for its transmission amongst pregnant women in 
Eastern region of Ghana. Finally, the study aimed at suggesting 
practical alternatives of HBV prevention.
MATERIALS AND METHODS
Between December 2008 and March 2009, data was collected 
from 1,500 pregnant women who visited three hospitals in East-
ern region of Ghana. The Eastern region occupies a land area of 
19,323 km and constitutes 8.1% of the total land area of Ghana. 
The population of Eastern region was 2.3 million in 2008 which 
was 9.8% of Ghanaian population and three study districts oc-
cupied 10.8% (0.25 million) of the Eastern region (Fig. 1). 
In three study districts of Eastern region, there were three 
hospitals; Holy Family Hospital (HFH) in Kwahu West district, 
Asesewa Government Hospital (AGH) in Upper Manya Krobo 
district, and Somanya Polyclinic (SPC) in Yilo Krobo district. 
HFH was an old general hospital established in 1945, has 3 doc-
tors and assisted by a number of professional doctors who visit 
the hospital regularly. While AGH was new district hospital, 
there was only one physician. In Yilo Krobo district including 
SPC, there were no physicians.
3 Aside from these hospitals there 
are also rural health centers; Reproductive & Child Health (RCH) 
or Community-based Health and Planning Services (CHPS). 
Public health workers are assigned in RCH or CHPS. Pregnant 
women visit RCH or CHPS to antenatal care or urgent delivery. 
We have trained nurses of three hospitals and they directly 
interviewed the pregnant women. After signing a written in-
formed consent, all the subjects responded to a questionnaire, 
which composed of six sections; general information, current 
pregnancy, pregnancy history, concerns, health care utilizations, 
and health examinations. They were screened for blood pres-
sure, blood sugar, anemia, HBsAg, human immunodeficiency 
virus (HIV), and sickle cell anemia. Hemoglobin levels less than 
10 g/dL was determined to be anemic. HIV was identified by 
HIV rapid antibody test performed using OraQuick Rapid HIV-
1/2 and confirmed with First Response manufactured by Ora-
Sure Technology Inc. (Bethlehem, PA, USA) and Premier Medi-
cal Co., Ltd. (Daman, India), respectively. HBsAg was done using 
serum with Accu-Tell
® HBsAg Strip manufactured by Accu Bio 
Tech Co., Ltd. (Beijing, China).
The Institutional Review Board of the Eulji University Hos-
pital approved the study protocol (IRB 08-38). Permission was 
sought from the Eastern Regional Health Directorate of the 
Ghana Health Service and written informed consent for use of 
questionnaires and medical records for research purposes was 
obtained from every study participant. 
We analyzed correlation between HBsAg positive women and 
estimated risk factors using cross-tabulation, and confirmed 
validity through chi-square test. Only the statistically significant 
variables were used to constitute the variable model, which was 
then analyzed using multiple logistic regression model. All the 
statistical analyses were run on SPSS version 18.0 (IBM, New 
York, NY, USA).
RESULTS
1. HBsAg positive rate by general characteristics 
The mean HBsAg positive rate for these subjects was 10.6%. 
It was different by the districts (p<0.001). The HBsAg positive 
rates of AGH and HFH were 12.4% and 13.8%, respectively, 
which were higher than that of SPC’s (2.2%). There were no 
significant age-related differences, but there was a significant 
difference according to education level of the subjects. Only 
7.7% of those who received primary education were positive for 
HBsAg, but among those who received education at secondary 
school or higher, 14.1% proved to be HBsAg positive. There was 
no statistically significant difference in gravidity (Table 1). 
2. HBsAg positive rate by self-reported social support and 
mental health status 
The pregnant women who answered ‘yes’ to the question ask-
ing whether they felt unsafe in their houses showed a higher 
HBsAg positive rate (p=0.042). No significant HBsAg positive 
rate difference existed depending on hunger, which was re-
Fig. 1. Map of Ghana. The three study districts were located in the 
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searched through the questionnaire asking whether they had 
missed any meals during the past month due to shortage of 
food supply. Also, no significant HBsAg positive rate difference 
was noticed between the groups who answered ‘yes’ and ‘no’ to 
the question asking whether they have had housing problems 
during the past 3 months. HBsAg positive rate of the group who 
answered ‘yes’ to the question ‘Do you have transportation, 
child care, or other problems that prevent you from receiving 
health care?’ was 20.9%, which was statistically higher than that 
of those who answered ‘no’ (p=0.003). The subjects who said 
they had depression and/or had received counseling or medica-
tion for mental health concerns ranked significantly higher in 
HBsAg positivity compared with subjects who said they had 
not. The question asking whether they had little interest in do-
ing things during the past month did not result in a statistically 
significant difference in HBsAg positive rates (Table 2). 
3. HBsAg positive rate by diseases 
As shown in Table 3, there was no significant correlation in 
HBsAg positive rates between subjects who had anemia and 
those who did not. No statistically significant difference in HB-
sAg positivity was found due to history of malaria or sickle cell 
anemia. Of 75 HIV-positive pregnant women, 14 had HBsAg, 
making 18.7% of the group. Of the 893 HIV-negative pregnant 
women, 81 had HBsAg, marking 9.1% of the group. We found 
out that there is a statistically significant difference in HBsAg 
positive rates between HIV carriers and non-carriers. Missing 
group on HIV test located between HIV positive and negative 
group. (p=0.008, Table 3).
4. Multiple logistic regression analysis for HBsAg positivity 
These results suggested chances of a causal relationship be-
tween several factors such as district, education, unsafe living 
conditions, health care problems, depression and HIV carrier 
and HBsAg positive rates. We reaffirmed the risk factors of 
hepatitis B through multiple logistic regression analyses.
Positivity of HBsAg was the highest in HFH, followed by that 
of AGH, which were 5.71 times and 4.29 times higher than that 
of SPC, respectively. Education, unsafe living conditions and 
health care problems had no statistical significance in HBsAg 
positive rates, unlike the results from cross-tabulation. The preg-
nant women with depression had HBsAg positive rate which 
was 3.74 times higher than that of those with no depression. 
The HIV positive group showed 2.03-times higher HBsAg posi-
tive rate compared to the HIV negative group, the difference of 
which was statistically significant (Table 4).
DISCUSSION
The study result highlights the fact that means HBsAg has a 
Table 1. The Hepatitis B Surface Antigen (HBsAg) Positive Rate Based 
on General Characteristics in Pregnant Women in Eastern Region of 
Ghana
Characteristic Total
HBsAg positive, 
No. (%)
p-value
Region  Yilo Krobo (SPC) 273 6 (2.2) <0.001
  (Hospital) Upper Manya 
  (AGH)
534 66 (12.4)
Kwahu West (HFH) 443 61 (13.8)
Age, yr <20 174 19 (10.7) 0.989
20-29 648 69 (10.5)
30+ 428 45 (10.7)
Education None 254 31 (12.2) 0.001
Primary 646 50 (7.7)
Secondary+ 326 46 (14.1)
Missing 24 6 (25.0)
Gravidity 1 339 40 (11.8) 0.236
2-3 355 28 (7.9)
4-5 350 39 (11.1)
6+ 206 26 (12.6)
Total 1,250 133 (10.6)
Table 2. The Hepatitis B Surface Antigen (HBsAg) Positive Rate Based 
on Self-Reported Social Support and Mental Health Status in Preg-
nant Women in Eastern Region of Ghana
Characteristic Total
HBsAg positive, 
No. (%)
p-
value*
Social support
   Unsafe house Yes 84 15 (17.9) 0.042
No 1,154 118 (10.2)
Missing 12 0 (0.0)
   Hunger Yes 80 14 (17.5) 0.058
No 1,167 119 (10.2)
Missing 3 0 (0.0)
   Housing problems Yes 154 11 (7.1) 0.162
No 1,092 122 (11.2)
Missing 4 0 (0.0)
   Health care problems Yes 86 18 (20.9) 0.003
No 1,157 115 (9.9)
Missing 7 0 (0.0)
Mental health
   Depression
† Yes 74 24 (32.4) <0.001
No 1,170 108 (9.2)
Missing 6 1 (16.7)
   Little interested Yes 262 34 (13.0) 0.216
No 976 99 (10.1)
Missing 12 0 (0.0)
Total 1,250 133 (10.6)
*p-value obtained by chi-square test except missing cases; 
†Depres-
sion and/or had received counseling or medication for mental health 
concerns.238  Gut and Liver, Vol. 6, No. 2, April 2012
positive rate 10.6% for 1,500 subjects is higher than the WHO 
recommended birth-dose standard of 8%. Some other stud-
ies reveal that 15.8% of HBV seroprevalence in Ghana
8 and a 
maximum of 20.9% of in antigen positive rate.
6 Yet there is no 
policy of birth-dose vaccination in Ghana. Birth dose vaccina-
tion should be considered in these areas with high prevalence. 
The prevalence rate of HBsAg among parturients or pregnant 
women in Accra, Ghana increased from 6.4% in 1994
9 to 10.5% 
in 2005,
10 which was similar to this study result. 
According to the recent population-based review study for 
the HBV seroprevalence, Ghana was grouped 1 (high endemic-
ity, i.e., >8% affected) and AFR-D (Africa with high child and 
high adult mortality).
11 Median seroprevalence estimate of HB-
sAg in pregnant women in group 1 region was 9.9%,
11 which 
was lower than the current study result. 
The present study also details the risk factors of HBV infec-
tion in pregnant women in Eastern Ghana. The HBsAg positive 
rates for AGH and HFH were 12.4% and 13.8%, respectively, 
which were higher than that of SPC (2.2%). According to the 
previous reports, HBV prevalence showed higher or similar 
rates in rural districts.
12,13 In this study, HFH is in the capital of 
a municipality and SPC is in a more urban district than AGH; 
there is not much difference in the prevalence between urban 
and rural consistent with previous reports.
12,13 According to our 
survey, inoculated rate of HBV vaccine in AGH, HFH, SPC were 
0.7%, 0.3%, and 1.1%, respectively which were very slight. In 
Ghana, it was not until 2002 that vaccination against hepatitis 
B started at government level.
2 In this study SPC district showed 
lower rates in variables which are related to HBsAg positvity 
compared to AGH and HFH (0.0%, 8.0%, and 6.4% for depres-
sion, 8.2%, 36.8%, and 11.8% for little interested, 1.3%, 9.5% 
and 7.2% for health care problems and 6.9%, 8.4%, and 9.4% 
Table 3. The Hepatitis B Surface Antigen (HBsAg) Positive Rate Based 
on Diseases in Pregnant Women in Eastern Region of Ghana
Characteristic Total
HBsAg positive, 
No. (%)
p-
value*
Anemia
† No 932 102 (10.9) 0.521
Yes 307 29 (9.4)
Missing 11 2 (18.2)
Malaria
‡ No 340 40 (11.8) 0.471
Yes 905 93 (10.3)
Missing 5 0 (0.0)
Sickling Negative 948 88 (9.3) 0.172
Positive 110 15 (13.6)
Missing 192 30 (15.6)
HIV Negative 893 81 (9.1) 0.008
Positive 75 14 (18.7)
Missing 282 38 (13.5)
Total 1,250 133 (10.6)
*p-value obtained by chi-square test except missing cases; 
†Anemia 
defined as <10 g/dL of hemoglobin level; 
‡Self-reported disease his-
tory.
Table 4. Multiple Logistic Regression Analysis for Hepatitis B Surface Antigen (HBsAg) Positivity in Pregnant Women in Eastern Region of Ghana
Characteristic No.
HBsAg positive, 
%
Adjusted OR 95% CI
Region (Hospital) Yilo Krobo (SPC) 273 2.2 1.0
Upper Manya (AGH) 529 12.5 4.29 1.75 10.50
Kwahu West (HFH) 424 14.2 5.71 2.24 14.56
Education None 250 12.0 1.0
Primary 635 7.9 0.84 0.50 1.41
Secondary+ 319 14.4 1.12 0.67 1.86
Missing 22 27.3 2.29 0.78 6.73
Unsafe house No 1,145 10.3 1.0
Yes 81 17.3 1.28 0.67 2.44
Health care problems No 1,143 10.0 1.0
Yes 83 21.7 1.39 0.75 2.56
Depression* No 1,156 9.3 1.0
Yes 70 34.3 3.74 2.13 6.57
HIV Negative 880 9.2 1.0
Positive 75 18.7 2.03 1.06 3.89
Missing 271 13.7 0.95 0.54 1.68
OR, odds ratio; CI, confidence interval; HIV, human immunodeficiency virus.
*Depression and/or had received counseling or medication for mental health concerns.Cho Y, et al: Prevalence and Risk Factors for HBsAg Positivity in Ghana  239
for HIV positive, respectively).
There was no significant difference with regards to the age. 
This result demonstrates that the vertical transmission is domi-
nant in these areas. Although the possibility of horizontal trans-
mission cannot be excluded considering peculiarity of Africa,
6 
importance of vertical transmission should be considered. Our 
results correspond with the other article, suggesting the major-
ity of hepatitis B infected children in Sub-Saharan Africa were 
infected before age 5 years.
7 Vertical transmission is said to 
be caused by three predominant methods: 1) trans-placental 
intrauterine transmission; 2) transmission during delivery by 
contact with maternal infected fluids in the birth canal; and 3) 
postnatal transmission from mothers to infants during childcare 
or through breast-feeding.
14,15
From our survey, 1,453 pregnant women out of 1,500 (98.2%) 
were planning to breastfeed their babies. Considering the high 
HBV prevalence in these areas, there is an urgent need to block 
off vertical transmission through these three passages with rec-
ommended HBV birth-dose vaccination.
5
There was no significant education-related difference. This 
result is in contrast to the previous data, suggesting hepatitis B 
infection is inversely related to education.
16 Our research needs 
further evaluation to figure out the accurate correlation between 
education and hepatitis B infection. How much hygiene edu-
cation and prevention is being undertaken in elementary and 
higher education; and how much education itself is contribut-
ing to hygiene improvement in Ghana should be researched in 
future studies. 
Mental health state correlated with HBsAg positivity. These 
findings correspond with the result of Atesci et al.
17 They dem-
onstrated that exposure to hepatitis B can influence patient’s 
mental status like depression. But in our study, we have a 
limitation of knowing whether the subjects were aware of their 
HBV infection state as there is no routine HBsAg screening test 
during pregnancy in Ghana. Prenatal and antenatal checkup 
services including HIV test is free in Ghana; however, HBsAg 
testing is not included in this routine. 
Further research will be required to explain this finding. In 
any case, supporting mental health needs to be considered when 
taking measures to prevent hepatitis B infection in pregnant 
women in Ghana.  
HIV positive group showed significantly higher HBsAg posi-
tive rate than HIV negative group (odds ratio, 2.03; 95% con-
fidence interval, 1.06 to 3.89). A study suggested that for HIV 
infected Africans, the rate of HBV co-infection is higher than 
European or Latin American.
18 Of the 35 million people liv-
ing with HIV worldwide, around 20% had HBV in some HBV 
endemic regions in sub-Saharan Africa whereas only 5% in 
Western countries.
19 On Multicentre AIDS Cohort Study (MACS) 
cohort, co-infected group showed 8 times high liver-related 
mortality than HIV mono-infected group.
20 Ghana, however, has 
a strong and comprehensive program aimed at virtual elimina-
tion of vertical transmission of HIV.
21 We believe that integrat-
ing prevention of vertical transmission of HBV into the HIV/
AIDS program will be effective considering that Eastern region 
is leading in prevalence of HIV in Ghana.
22
The current study has limitations. Firstly, we only test HBsAg 
among serologic markers for hepatitis B viral infection; no data 
of serum HBV titer, hepatitis B e antigen/antibody to hepatitis 
B e antigen. Secondly, we use rapid test instead of Enzyme Im-
munoassay (EIA) for HBsAg; Accu-Tell
® One Step HBsAg Whole 
Blood Test, which is a rapid, immunochromatographic assay 
for the qualitative detection of HBsAg in human whole blood, 
serum or plasma. However, the validity was acceptable level; 
when the test results were compared to EIA, the sensitivity was 
98.89% and the specificity was 98.87%. When the test results 
were compared to Radioimmunoassay, they were 100.00%, and 
99.43%, respectively.
23
In spite of these limitations, this current study clearly dem-
onstrates high HBV prevalence and risk factors in pregnant 
women in Eastern Ghana. Further studies will be required to 
take measures for each risk factor including traditional life style 
and folk medicine. It is our belief that HBV screening test for 
pregnant women and HBV vaccination after birth can be effica-
cious in Eastern Ghana.
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